Entity

Time filter

Source Type

Foster City, CA, United States

The present application includes novel modulators of TLRs, compositions containing such compounds, therapeutic methods that include the administration of such compounds.


Patent
Gilead Sciences Inc. | Date: 2015-06-10

The present application provides the compounds of formula (J), or pharmaceutically acceptable salts, isomers, tautomer, or a mixture thereof, wherein n, W, A, B, R


Patent
Gilead Sciences Inc. | Date: 2015-04-08

Methods for isolating 9-{(R)-2-[((S)-{[(S)-1-(isopropoxycarbonyl)ethyl]amino}phenoxyphosphinyl)methoxy]propyl}adenine (compound 16): a method for preparing, in high diastereomeric purity, intermediate compounds 13 and 15: and a method for preparing intermediate compound 12: 9-{(R)-2-[((S)-{[(S)-1-(isopropoxycarbonyl)ethyl]amino}phenoxyphosphinyl)methoxy]propyl}adenine has anti-viral properties.


Patent
Gilead Sciences Inc. | Date: 2015-02-05

The invention provides synthetic processes and synthetic intermediates that can be used to prepare compounds having useful anti-HIV properties.


Patent
Gilead Sciences Inc. | Date: 2015-10-01

The present disclosure relates to compounds that are sodium channel inhibitors and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. In particular embodiments, the structure of the compounds is given by Formula I: wherein Z

Discover hidden collaborations